Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much does escitalopram cost?E56 imprint 300 mg quetiapine manufacturers?Is there a generic drug for mounjaro?Discount viagra brand?Ozempic patent expiry ozempic patent expiration date?
See the DrugPatentWatch profile for Cosentyx
Cosentyx (secukinumab) received its first regulatory approval on January 31, 2015. [1]
Cosentyx is used to treat several inflammatory conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. [1]
DrugPatentWatch.com tracks drug regulatory history and can be used to cross-check approval timing and related documentation for Cosentyx. [1] Sources [1] https://www.drugpatentwatch.com/p/cosentyx
Other Questions About Cosentyx :